» Articles » PMID: 10694210

Functional Neuroimaging of Cognition Impaired by a Classical Antihistamine, D-chlorpheniramine

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2000 Feb 29
PMID 10694210
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Antihistamine induced cognitive decline was evaluated using positron emission tomography (PET) measurement of histamine H1 receptor (H1R) occupancy and regional cerebral blood flow (rCBF). Cognitive performance in attention-demanding task deteriorated dose-dependently and the effects were statistically significant after the treatment of 2 mg of d-chlorpheniramine. There was no significant change in subjective sleepiness in the same dose. The regional blockade of H1R was observed mainly in the frontal, temporal and anterior cingulate cortices, and the intravenous administration of d-chlorpheniramine as a therapeutic dose (2 mg) blocked over 60% of H1R in the frontal cortices. The results from activation study using visual discrimination tasks demonstrated that enhanced activity in the right prefrontal and anterior cingulate cortices as well as a decreased activity in the left temporal and frontal cortices and midbrain after the treatment of d-chlorpheniramine. There were no changes in global CBF for the subjects treated with 2 mg d-chlorpheniramine (pre; 44.8+/-3.3 ml dl(-1) min(-1) vs post; 44.4+/-4.7 ml dl(-1) min(-1)). The results indicated that the attention system of human brain could be altered by therapeutic doses of H1R antagonists. These findings provide the information as to the potential risk of antihistamines in our daily activities. British Journal of Pharmacology (2000) 129, 115 - 123

Citing Articles

Targeting Histamine and Histamine Receptors for Memory Regulation: An Emotional Perspective.

Fang Z, Chen J, Zheng Y, Chen Z Curr Neuropharmacol. 2024; 22(11):1846-1869.

PMID: 38288837 PMC: 11284729. DOI: 10.2174/1570159X22666240128003108.


Molecular mechanism of antihistamines recognition and regulation of the histamine H receptor.

Wang D, Guo Q, Wu Z, Li M, He B, Du Y Nat Commun. 2024; 15(1):84.

PMID: 38167898 PMC: 10762250. DOI: 10.1038/s41467-023-44477-4.


Old versus new antihistamines: Effects on cognition and psychomotor functions.

Shamil K, Prakruti P, Anuradha M, Bela J, Chetna K J Family Med Prim Care. 2023; 11(10):5909-5917.

PMID: 36618177 PMC: 9810909. DOI: 10.4103/jfmpc.jfmpc_77_22.


Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.

Russo M, De Rosa M, Calisi D, Consoli S, Evangelista G, Dono F Int J Mol Sci. 2022; 23(19).

PMID: 36232720 PMC: 9569564. DOI: 10.3390/ijms231911418.


Histamine H receptor on astrocytes and neurons controls distinct aspects of mouse behaviour.

Karpati A, Yoshikawa T, Naganuma F, Matsuzawa T, Kitano H, Yamada Y Sci Rep. 2019; 9(1):16451.

PMID: 31712580 PMC: 6848115. DOI: 10.1038/s41598-019-52623-6.


References
1.
Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y . Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 1984; 295(1):13-25. DOI: 10.1016/0006-8993(84)90811-4. View

2.
Raichle M, Martin W, Herscovitch P, Mintun M, Markham J . Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med. 1983; 24(9):790-8. View

3.
Kemp J, Buckley C, Gershwin M, Buchman E, Cascio F, Chretien J . Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann Allergy. 1985; 54(6):502-9. View

4.
Seidel W, Cohen S, Bliwise N, Dement W . Cetirizine effects on objective measures of daytime sleepiness and performance. Ann Allergy. 1987; 59(6 Pt 2):58-62. View

5.
Lin J, Sakai K, Jouvet M . Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology. 1988; 27(2):111-22. DOI: 10.1016/0028-3908(88)90159-1. View